Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Blood (2025) 146 (Supplement 1): 1854.

https://doi.org/10.1182/blood-2025-1854

Published: 2025

Journal Articles

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Blood (2025) 146 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2025-4417

Published: 2025

Journal Articles

Genomic assessment of acquired mutations in participants with CLL/SLL treated with nemtabrutinib in the Phase 2 bellwave-003 study

Blood (2025) 146 (Supplement 1): 797.

https://doi.org/10.1182/blood-2025-797

Published: 2025

Journal Articles

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Blood (2025) 146 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2025-3673

Published: 2025

Journal Articles

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Blood (2025) 146 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2025-5391

Published: 2025

Journal Articles

High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience

Newton Centurião, Danielle Ovigli, Fernando Moura, Andreza Ribeiro, Cinthya Da Silva, Guilherme Perini, Ricardo Helman, Lucila Kerbauy, Juliana Rocha, João Guerra, Jose Kutner, Fabio Pires, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 6900.

https://doi.org/10.1182/blood-2025-6900

Published: 2025

Journal Articles

Access to diagnostics, therapies, and advanced care for lymphoma in Latin America: A multicenter, survey-based study

Blood (2025) 146 (Supplement 1): 6193.

https://doi.org/10.1182/blood-2025-6193

Published: 2025

Journal Articles

Outcomes of diffuse large B-cell lymphoma and high-grade B-cell lymphoma in elderly patients aged ≥ 80 years-old treated in first line therapy: An analysis of the bra-DLBCL multicenter, real-world registry, retrospective study

Carolina Feres, Guilherme Perini, Larissa Teixeira, Rafael Gaiolla, Talita Silveira, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8070.

https://doi.org/10.1182/blood-2025-8070

Published: 2025

Journal Articles

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 1361.

https://doi.org/10.1182/blood-2025-1361

Published: 2025

Journal Articles

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with Relapsed/Refractory follicular lymphoma (R/R FL): Phase 1/2 study extended follow-up Results

Julio Chavez, Jason Westin, Javier Munoz, Emmanuel Bachy, Judit Jørgensen, Guilherme Perini, Daniel Morillo, Abel Costa, Parth Rao, Berengere De Moucheron, Gang Yang, Soraya Carrancio, Akshay Sudhindra, Michael Pourdehnad, Jessica Voetsch, Serena Perna, Jean-Marie Michot

Blood (2025) 146 (Supplement 1): 1006.

https://doi.org/10.1182/blood-2025-1006

Published: 2025

Journal Articles

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy

Guilherme Perini, Ahmad Alhuraiji, Mary Ann Anderson, Gilberto Israel Barranco Lampón, Otavio Cesar Carvalho Guimarães Baiocchi, Ahmet Emre Eskazan, Yeow Tee Goh, Wei-Han Huang, Mervat Mattar, Evgeny Nikitin, Stephen Opat, Miguel Pavlovsky, Wei Xu

Blood (2025) 146 (Supplement 1): 7937.

https://doi.org/10.1182/blood-2025-7937

Published: 2025

Journal Articles

The impact of high-grade B-cell lymphoma morphology compared with diffuse large B-cell lymphoma in a cohort from bra-DLBCL, a multicenter, real-world study from Brazil

Rafael Gaiolla, Talita Silveira, Carolina Feres, Larissa Teixeira, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Guilherme Perini, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8102.

https://doi.org/10.1182/blood-2025-8102

Published: 2025

Journal Articles

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Blood (2025) 146 (Supplement 1): 2405.

https://doi.org/10.1182/blood-2025-2405

Published: 2025

Journal Articles

Peripheral blood or bone marrow grafts for unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

Leonardo Arcuri, Victor Natal, Mariana Kerbauy, Guilherme Perini, Andreza Ribeiro, Nelson Hamerschlak, Carla Ribeiro

Blood (2025) 146 (Supplement 1): 6002.

https://doi.org/10.1182/blood-2025-6002

Published: 2025

Journal Articles

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Blood (2025) 146 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2025-7066

Published: 2025

Journal Articles

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Blood (2025) 146 (Supplement 1): 7055.

https://doi.org/10.1182/blood-2025-7055

Published: 2025

Journal Articles

Non-GCB cell of origin leads to inferior outcomes in brazilian diffuse large B-cell lymphoma patients: Bra-DLBCL multicenter registry, retrospective study of over 500 patients

Guilherme Perini, Larissa Teixeira, Carolina Feres, Talita Silveira, Rafael Gaiolla, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 6323.

https://doi.org/10.1182/blood-2025-6323

Published: 2025

Journal Articles

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Phase 1/2 study extended follow-up Results

Blood (2025) 146 (Supplement 1): 479.

https://doi.org/10.1182/blood-2025-479

Published: 2025

Journal Articles

Analysis of lymphoma subtypes, involved sites, and treatment outcomes in primary gastrointestinal B-cell lymphomas: A subset analysis within the PELÉ study of brazilian centers.

Blood (2025) 146 (Supplement 1): 2760.

https://doi.org/10.1182/blood-2025-2760

Published: 2025

Journal Articles

The impact of public versus private health care services in the treatment of diffuse large B-cell lymphoma in Brazil: An analysis from the bra-DLBCL multicenter, retrospective real-world registry

Talita Silveira, Guilherme Perini, Larissa Teixeira, Carolina Feres, Rafael Gaiolla, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8011.

https://doi.org/10.1182/blood-2025-8011

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Genomic assessment of acquired mutations in participants with CLL/SLL treated with nemtabrutinib in the Phase 2 bellwave-003 study

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience

Access to diagnostics, therapies, and advanced care for lymphoma in Latin America: A multicenter, survey-based study

Outcomes of diffuse large B-cell lymphoma and high-grade B-cell lymphoma in elderly patients aged ≥ 80 years-old treated in first line therapy: An analysis of the bra-DLBCL multicenter, real-world registry, retrospective study

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with Relapsed/Refractory follicular lymphoma (R/R FL): Phase 1/2 study extended follow-up Results

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy

The impact of high-grade B-cell lymphoma morphology compared with diffuse large B-cell lymphoma in a cohort from bra-DLBCL, a multicenter, real-world study from Brazil

Results of the first Latin American point of care manufactured, Phase I anti- CD19 CAR-T study (CARTHIAE) for Relapsed/Refractory B-cell neoplasms

Peripheral blood or bone marrow grafts for unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Non-GCB cell of origin leads to inferior outcomes in brazilian diffuse large B-cell lymphoma patients: Bra-DLBCL multicenter registry, retrospective study of over 500 patients

Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, ± rituximab (R) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Phase 1/2 study extended follow-up Results

Analysis of lymphoma subtypes, involved sites, and treatment outcomes in primary gastrointestinal B-cell lymphomas: A subset analysis within the PELÉ study of brazilian centers.

The impact of public versus private health care services in the treatment of diffuse large B-cell lymphoma in Brazil: An analysis from the bra-DLBCL multicenter, retrospective real-world registry

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only